Brainstorm Cell Therapeutics Stock Market Value
| BCLI Stock | USD 0.53 0.00 0.000006% |
| Symbol | Brainstorm |
Is there potential for Biotechnology market expansion? Will Brainstorm introduce new products? Factors like these will boost the valuation of Brainstorm Cell. Projected growth potential of Brainstorm fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainstorm Cell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainstorm Cell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainstorm Cell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Brainstorm Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Brainstorm Cell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Brainstorm Cell.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Brainstorm Cell on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Brainstorm Cell Therapeutics or generate 0.0% return on investment in Brainstorm Cell over 90 days. Brainstorm Cell is related to or competes with Neurosense Therapeutics, Matinas BioPharma, Adial Pharmaceuticals, Cardio Diagnostics, HCW Biologics, Impact BioMedical, and Acurx Pharmaceuticals. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologo... More
Brainstorm Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Brainstorm Cell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Brainstorm Cell Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 9.09 |
Brainstorm Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainstorm Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Brainstorm Cell's standard deviation. In reality, there are many statistical measures that can use Brainstorm Cell historical prices to predict the future Brainstorm Cell's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.42) |
Brainstorm Cell February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 3.86 | |||
| Coefficient Of Variation | (3,122) | |||
| Standard Deviation | 5.04 | |||
| Variance | 25.41 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 24.01 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 9.09 | |||
| Skewness | 0.4459 | |||
| Kurtosis | 0.133 |
Brainstorm Cell Ther Backtested Returns
Brainstorm Cell Ther secures Sharpe Ratio (or Efficiency) of -0.0291, which signifies that the company had a -0.0291 % return per unit of standard deviation over the last 3 months. Brainstorm Cell Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Brainstorm Cell's risk adjusted performance of (0.02), and Mean Deviation of 3.86 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Brainstorm Cell's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brainstorm Cell is expected to be smaller as well. At this point, Brainstorm Cell Ther has a negative expected return of -0.14%. Please make sure to confirm Brainstorm Cell's standard deviation and the relationship between the total risk alpha and day typical price , to decide if Brainstorm Cell Ther performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.24 |
Weak reverse predictability
Brainstorm Cell Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Brainstorm Cell time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Brainstorm Cell Ther price movement. The serial correlation of -0.24 indicates that over 24.0% of current Brainstorm Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Brainstorm Cell Correlation, Brainstorm Cell Volatility and Brainstorm Cell Performance module to complement your research on Brainstorm Cell. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Brainstorm Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.